The causes are diverse, and the diagnosis may be challenging. Take this quick quiz to test your knowledge.
A 6-year-old girl had painful red nodules on her shins that had been present for 2 weeks. She had no fever but did have a sore throat a few weeks earlier that had resolved. After a thorough history it was determined that the girl had erythema nodosum, the most common type of panniculitis.
Panniculitis can be a disease by itself or a manifestation of an underlying disease. It has diverse causes, and often the cause is unknown, but many forms have the same clinical appearance, often making the diagnosis a challenge. Take this quick quiz to test your knowledge.
Note: If you would like more information on any of the questions, a link to the original article, “Knee Knots in a Young Girl: What's Your Diagnosis?” is provided on the last page of the quiz.
Question 1:
Answer and Question #2 on Next Page »
The correct answer is C. Infiltration of subcutaneous tissues can involve either inflammatory or neoplastic cells.
Question 2.
Answer and Question #3 on Next Page »
The correct answer is B. Loss of pigment in the skin
Question 3.
Answer and Question #4 on Next Page »
The correct answer is A. Septal and lobular
Question 4.
Answer and Question #5 on Next Page »
The correct answer is B. Predominance of inflammation involves the connective tissue septa between the fat lobules.
Question 5.
Answer and Question #6 on Next Page »
The correct answer is D. It’s suppurative.
Question 6.
Answer and Question #7 on Next Page »
The correct answer is E. A and B but not C
Question 7.
Answer and Question #8 on Next Page »
The correct answer is B. Streptococcal
Question 8.
Answer on Next Page »
The correct answer is A. True
For more information on all questions and answers, please visit “Knee Knots in a Young Girl: What's Your Diagnosis?”
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.